Halozyme Therapeutics Inc. (NASDAQ: HALO), a biopharmaceutical company engaged in the development and commercialization of products that advance patient care, is seeing a pullback in mid-day trading today after rallying on Friday.
HALO had finished nearly 27% on Friday after the company announced that it entered into collaboration with pharmaceutical major Pfizer Inc. (NYSE: PFE) to develop and commercialize subcutaneous biologics using recombinant human hyaluronidase. The stock broke through some key technical levels on Friday as a result of the rally. Technical indicators for the stock are still giving bullish signals despite the pullback in trading today.
HALO is currently trading 1.86% lower at $6.88 on volume of 710,923, which is below the daily average volume of 910,288.
Acura Pharmaceuticals Inc. (NASDAQ: ACUR), a specialty pharmaceutical company engaged in the research, development and commercialization of products focused on addressing medication abuse and misuse, is marginally lower in mid-day trading today, extending its losses from last week.
ACUR fell sharply last week even as the company announced submission of Investigational New Drug Application (IND) with the U.S. FDA to allow clinical testing of its hydrocodone bitartrate with acetaminophen formulated with Aversion® Technology. The company said that clinical testing can start under the IND 30 days after the IND filing unless the FDA raises any questions.
ACUR is currently trading 0.44% lower at $2.30 on volume of 38,748, which is well below the daily average volume of 821,571. The stock has now fallen more than 6% in the last three trading sessions.
Get everything traders and investors need to know about ACUR by getting the free full report here: http://www.monstertradingalerts.com/market-scan/?symbol=ACUR
MonsterTradingAlerts.com issues momentum alerts on stocks that can provide gains to day traders. MonsterTradingAlerts.com provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. MonsterTradingAlerts.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals MonsterTradingAlerts.com is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the MonsterTradingAlerts.com newsletter and receiving alerts from a Pro-Active team of researchers. Trading Alerts believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www. MonsterTradingAlerts.com
Disclosure: MonsterTradingAlerts.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit MonsterTradingAlerts.com website, for complete risks and disclosures.
Alexander K. Neumann
Monster Trading Alerts
SOURCE Investor Alley, Inc.